Celexa/Lexapro MDL winds up

Wednesday, Jan 31, 2018
  • Lexapro Medical Record Review & Outsourcing Services

The U.S. District Judge Nathaniel M. Gorton granted Forest Laboratories’ motion for summary judgment on all claims made by the plaintiffs who alleged that the company fraudulently promoted Celexa and Lexapro for pediatric depression. This ruling brings an end to the long-running Massachusetts MDL 2067: In Re: Celexa and Lexapro Marketing and Sales Practices Litigation.

We are social:

Accreditations

HIPAA

Neural IT has successfully implemented HIPAA for securing Health records....

ISO 27001 Certification

Neural IT has successfully passed the ISMS re-certification audit and is now ISO 27001:2013 certi...

NSIC - CRISIL

NSIC-CRISIL has assigned a "SE 2A" rating to Neural IT, indicating a company with High Performanc...

Associations

CAALA

CAALA - "Neural IT is proud to be associated with CAALA (Consumer Attorneys Association of Los An...

CAOC

CAOC - "Neural IT is proud to be associated with CAOC (Consumer Attorneys of California) as a Ven...

NYSTLA

NYSTLA - "Neural IT is proud to be associated with NYSTLA (New York State Trial Lawyers Associati...

News & Events

MTMP Spring Conference - 2018
Neural IT Team got to pose with Mike Papantonio at the successful book signing event of ‘Law And
Neural IT Celebrates 14 Jubilant years of Accomplishments & Achievements!
Neural IT Celebrates 14 Jubilant years of Accomplishments & Achievements!
2nd Quarter 2018 Rewards & Recognition Program Celebrations
2nd Quarter 2018 ‘Rewards & Recognition Program’ Celebrations at NEURAL IT

Latest Tweets